126 related articles for article (PubMed ID: 19091704)
1. Immunosuppressant drugs for myasthenia gravis.
Hart IK; Sharshar T; Sathasivam S
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):5-6; discussion 6. PubMed ID: 19091704
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive agents for myasthenia gravis.
Hart IK; Sathasivam S; Sharshar T
Cochrane Database Syst Rev; 2007 Oct; (4):CD005224. PubMed ID: 17943844
[TBL] [Abstract][Full Text] [Related]
3. Steroids and immunosuppressant drugs in myasthenia gravis.
Sathasivam S
Nat Clin Pract Neurol; 2008 Jun; 4(6):317-27. PubMed ID: 18493241
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Palace J; Newsom-Davis J; Lecky B
Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
[TBL] [Abstract][Full Text] [Related]
5. Medical treatment options for ocular myasthenia gravis.
Antonio-Santos AA; Eggenberger ER
Curr Opin Ophthalmol; 2008 Nov; 19(6):468-78. PubMed ID: 18854691
[TBL] [Abstract][Full Text] [Related]
6. [Bullous pemphigoid: a review].
Bernard P; Charneux J
Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
[TBL] [Abstract][Full Text] [Related]
7. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
Muscle Study Group
Neurology; 2008 Aug; 71(6):394-9. PubMed ID: 18434639
[TBL] [Abstract][Full Text] [Related]
8. Lessons from two trials of mycophenolate mofetil in myasthenia gravis.
Sanders DB; Siddiqi ZA
Ann N Y Acad Sci; 2008; 1132():249-53. PubMed ID: 18567876
[TBL] [Abstract][Full Text] [Related]
9. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
Sanders DB; Hart IK; Mantegazza R; Shukla SS; Siddiqi ZA; De Baets MH; Melms A; Nicolle MW; Solomons N; Richman DP
Neurology; 2008 Aug; 71(6):400-6. PubMed ID: 18434638
[TBL] [Abstract][Full Text] [Related]
10. A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis.
Ahn SW; Joo IS; Kim BJ; Sung JJ; Kang SY; Oh J; Minn YK; Suh BC; Oh SY; Hong YH; Nam TS; Seok JI; Park YE; Shin HY; Cho EB; Shin JY; Seok HY; Park JS; Min JH; Seok JM; Kim BJ
J Neurol Sci; 2017 Aug; 379():271-275. PubMed ID: 28716258
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.
Orth T; Peters M; Schlaak JF; Krummenauer F; Wanitschke R; Mayet WJ; Galle PR; Neurath MF
Am J Gastroenterol; 2000 May; 95(5):1201-7. PubMed ID: 10811328
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with prednisolone and tacrolimus for myasthenia gravis with invasive thymoma.
Miura S; Azuma K; Yamada K; Takamori S; Kawahara A; Noda K; Ayabe M; Kage M; Aizawa H; Taniwaki T
Acta Neurol Belg; 2010 Mar; 110(1):107-9. PubMed ID: 20514937
[TBL] [Abstract][Full Text] [Related]
13. [Recent clinical trials on treatment of myasthenia gravis].
Yoshikawa H
Rinsho Shinkeigaku; 2012; 52(11):832-5. PubMed ID: 23196436
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Myasthenia gravis treated with high-dose prednisolone and azathioprine: A single centre ambispective study from India.
Dube M; Sodani A; Chouksey D
Acta Neurol Taiwan; 2017 Sep; 26(3)():106-119. PubMed ID: 29468619
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive therapies in myasthenia gravis.
Sanders DB; Evoli A
Autoimmunity; 2010 Aug; 43(5-6):428-35. PubMed ID: 20166870
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus in refractory patients with myasthenia gravis: coadministration and tapering of oral prednisolone.
Shimojima Y; Matsuda M; Gono T; Ishii W; Tokuda T; Ikeda S
J Clin Neurosci; 2006 Jan; 13(1):39-44. PubMed ID: 16307880
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.
Schneider-Gold C; Hartung HP; Gold R
Muscle Nerve; 2006 Sep; 34(3):284-91. PubMed ID: 16583368
[TBL] [Abstract][Full Text] [Related]
19. Maintenance immunosuppression in myasthenia gravis.
Gotterer L; Li Y
J Neurol Sci; 2016 Oct; 369():294-302. PubMed ID: 27653912
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis.
Shimojima Y; Gono T; Yamamoto K; Hoshi K; Matsuda M; Yoshida K; Ikeda S
Clin Rheumatol; 2004 Jun; 23(3):262-5. PubMed ID: 15168159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
